People · Operator

Richard A. Sandberg

Named in public records as an officer, director or promoter · active 2004–2017 · Biotechnology, Other Health Care

2
Companies
2
Filings
$13.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Resolys Bio, Inc.BiotechnologySeries A$10.0M$361.5M2017
Cylex IncOther Health CareSeed$3.3M$81.8M2004
Operator network

Richard A. Sandberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Chris Garabedian · 8 companies · 1 sharedChris GarabedianJeffrey A. Eckmann · 2 companies · 1 sharedJeffrey A. EckmannJohn McMichael · 2 companies · 1 sharedJohn McMichaelThomas A. Hatch · 2 companies · 1 sharedThomas A. HatchJames A. Tobin · 1 companies · 1 sharedJames A. TobinThomas C. Hatch · 1 companies · 1 sharedThomas C. HatchW. Gregory Shearer · 2 companies · 1 sharedW. Gregory ShearerBrad L Stewart · 1 companies · 1 sharedBrad L StewartDouglas J Brown · 1 companies · 1 sharedDouglas J BrownJoseph Gregory Bloch, M.D. · 1 companies · 1 sharedJoseph Gregory Bl…Joseph Gregory Falkenstein · 1 companies · 1 sharedJoseph Gregory Fa…Richard J Kowalski, Ph.D. · 1 companies · 1 sharedRichard J Kowalsk…Resolys Bio, Inc. · $10.0M raisedResolys Bio, Inc.Cylex Inc · $3.3M raisedCylex IncRichard A. SandbergRS
Richard A. Sandberg Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Richard A. Sandberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Chris Garabedian18
John McMichael12
Jeffrey A. Eckmann12
Thomas A. Hatch12
W. Gregory Shearer12
James A. Tobin11
Joseph Gregory Bloch, M.D.11
Douglas J Brown11
Joseph Gregory Falkenstein11
Thomas C. Hatch11
Brad L Stewart11
Richard J Kowalski, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.